Studies have shown that the IL-6/STAT3 signaling pathway is associated with PCa progression, and that serum levels of IL-6 are higher in patients with metastatic PCa and CRPC compared to those with localized PCa. This evidence concerns the gene STAT3 and posterior cortical atrophy.